Aviir

Aviir, Inc., founded with a mission to revolutionize cardiovascular disease prevention and management, specializes in diagnostic technology. The company provides a range of cardiometabolic tests and services aimed at assessing and mitigating the risk of cardiovascular diseases. Their offerings include comprehensive wellness assessments that cover metabolic, thyroid, lipid profiles, and other critical blood chemistries, alongside specialized cardiovascular disease risk assessments and cardiometabolic syndrome diagnoses.

Notable figures affiliated with Aviir include leading experts in cardiology and metabolic health, contributing to the company's robust scientific foundation. Aviir has garnered attention from prominent investors in the healthcare sector, bolstering its research and development capabilities. The company's key achievements include the development of advanced diagnostic tools that have significantly impacted patient outcomes by enabling early detection and personalized management of cardiovascular conditions. Through its innovative approach, Aviir has made substantial contributions to the field of preventive cardiology.